The use of mass spectrometry imaging to predict treatment response of patient-derived xenograft models of triple-negative breast cancer.
暂无分享,去创建一个
Jos Jonkers | Ron M A Heeren | Gert B. Eijkel | Nadine E Mascini | R. Heeren | J. Wesseling | J. Jonkers | Jelle Wesseling | Gert B Eijkel | Petra ter Brugge | N. Mascini | Petra ter Brugge
[1] Z. Szallasi,et al. Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] André M Deelder,et al. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity , 2010, The Journal of pathology.
[3] Stefan K. Maier,et al. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria , 2013, The Journal of pathology.
[4] Liam A. McDonnell,et al. Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma , 2011, PloS one.
[5] Wolfgang Heller,et al. Triple-negative breast cancer: therapeutic options. , 2007, The Lancet. Oncology.
[6] Arend Heerschap,et al. A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy. , 2003, Analytical chemistry.
[7] Sören-Oliver Deininger,et al. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.
[8] Richard M Caprioli,et al. Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics , 2004, Cancer Research.
[9] Karin Jirström,et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.
[10] Gert B. Eijkel,et al. Time-of-flight secondary ion mass spectrometry-based molecular distribution distinguishing healthy and osteoarthritic human cartilage. , 2012, Analytical chemistry.
[11] Gert B. Eijkel,et al. Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage. , 2013, Arthritis and rheumatism.
[12] R. Caprioli,et al. Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation , 2010, Clinical Cancer Research.
[13] A. Smilde,et al. How to distinguish healthy from diseased? Classification strategy for mass spectrometry‐based clinical proteomics , 2007, Proteomics.
[14] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[15] Horst Zitzelsberger,et al. Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. , 2012, Journal of proteome research.
[16] R. Casadonte,et al. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry , 2011, Nature Protocols.
[17] M. Clench,et al. Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.
[18] C. Perou,et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.
[19] Pierre P Massion,et al. High‐throughput proteomic analysis of formalin‐fixed paraffin‐embedded tissue microarrays using MALDI imaging mass spectrometry , 2008, Proteomics.
[20] Gert B. Eijkel,et al. Correlating MALDI and SIMS imaging mass spectrometric datasets of biological tissue surfaces , 2009 .
[21] P. G. Kistemaker,et al. Discriminant analysis by double stage principal component analysis , 1983 .
[22] Detlev Suckau,et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.
[23] E. Raso,et al. Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging , 2012, Analytical and Bioanalytical Chemistry.
[24] Ara Darzi,et al. Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer , 2014, Proceedings of the National Academy of Sciences.